Want to see JP:2373 full AI Analyst Report?
Top Page
Care Twentyone Corporation
(2373)
Select Model
Select Model
Rating:49Neutral
Price Target:
¥406.00
▼(-2.64% Downside)
Action:Reiterated
Date:08/04/26
The score is held back primarily by elevated financial risk from a highly levered balance sheet and very thin profitability, despite strong revenue growth and improved recent cash generation. Technical indicators also point to weak/soft momentum, and valuation is pressured by a high P/E even with a solid dividend yield.
Positive Factors
Revenue Growth Momentum
Sustained top-line growth that accelerated in 2025 indicates expanding demand and market penetration for core services. Over a 2–6 month horizon this durable revenue momentum supports operating leverage, scale benefits, and a stronger baseline to improve margins and cash flow.
Negative Factors
High Leverage
Very high leverage (D/E >4x) materially reduces financial flexibility and amplifies risk from rate moves or revenue swings. Over months this constraint limits capacity to invest, raises refinancing risk, and forces cash flow to prioritize debt service rather than growth or margin improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth Momentum
Sustained top-line growth that accelerated in 2025 indicates expanding demand and market penetration for core services. Over a 2–6 month horizon this durable revenue momentum supports operating leverage, scale benefits, and a stronger baseline to improve margins and cash flow.
Read all positive factors
Care Twentyone Corporation (2373) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥5.44B
Dividend Yield4.21%
Average Volume (3M)53.50K
Price to Earnings (P/E)51.9
Beta (1Y)0.35
Revenue Growth4.85%
EPS Growth-85.27%
CountryJP
Employees6,319
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)7.79
Shares Outstanding14,844,000
10 Day Avg. Volume130,370
30 Day Avg. Volume53,500
Financial Highlights & Ratios
PEG Ratio0.44
Price to Book (P/B)1.46
Price to Sales (P/S)0.13
P/FCF Ratio3.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Care Twentyone Corporation Business Overview & Revenue Model
Company Description
Care Twentyone Corporation operates as a comprehensive welfare company in Japan. The company offers home care, paid nursing home, dementia group home, in-home care support, small-scale multi-functional home care, day service, and welfare equipment...
How the Company Makes Money
null...
Care Twentyone Corporation Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
39
Negative
Cash Flow
62
Positive
| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.35B | 48.16B | 45.40B | 41.10B | 38.40B | 36.36B |
| Gross Profit | 11.68B | 10.62B | 9.19B | 8.61B | 8.97B | 8.51B |
| EBITDA | 2.49B | 2.17B | 937.91M | 1.20B | 2.58B | 2.91B |
| Net Income | 105.31M | 384.18M | 278.42M | 6.16M | 630.49M | 937.08M |
Balance Sheet | ||||||
| Total Assets | 31.78B | 32.09B | 32.94B | 32.88B | 36.38B | 37.60B |
| Cash, Cash Equivalents and Short-Term Investments | 4.83B | 4.17B | 3.08B | 2.61B | 1.88B | 2.83B |
| Total Debt | 19.23B | 18.55B | 19.49B | 18.34B | 22.51B | 22.96B |
| Total Liabilities | 27.52B | 27.60B | 28.21B | 27.36B | 29.90B | 30.83B |
| Stockholders Equity | 4.17B | 4.42B | 4.71B | 5.50B | 6.46B | 6.77B |
Cash Flow | ||||||
| Free Cash Flow | 2.02B | 2.02B | -367.10M | 630.16M | 349.82M | 1.58B |
| Operating Cash Flow | 2.17B | 2.17B | 709.85M | 2.14B | 1.11B | 2.61B |
| Investing Cash Flow | 139.26M | 139.26M | -1.02B | -2.60B | -1.39B | -1.38B |
| Financing Cash Flow | -1.20B | -1.20B | 782.01M | 1.20B | -679.93M | -1.33B |
Care Twentyone Corporation Technical Analysis
Negative
417.00
Price Trends
408.00
Negative
415.58
Negative
428.47
Negative
Market Momentum
-0.90
Negative
46.86
Neutral
25.93
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2373, the sentiment is Negative. The current price of 417 is above the 20-day moving average (MA) of 403.20, above the 50-day MA of 408.00, and below the 200-day MA of 428.47, indicating a neutral trend. The MACD of -0.90 indicates Negative momentum. The RSI at 46.86 is Neutral, neither overbought nor oversold. The STOCH value of 25.93 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2373.
Care Twentyone Corporation Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥47.41B | 11.50 | ― | 2.63% | 5.16% | 37.79% | |
72 Outperform | ¥3.03B | 6.83 | ― | 2.82% | 5.48% | 13.46% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥2.57B | 30.49 | ― | 2.56% | -5.72% | -73.78% | |
51 Neutral | ¥1.30B | 10.97 | ― | ― | 9.08% | 30.71% | |
49 Neutral | ¥5.44B | 51.86 | ― | 4.07% | 4.85% | -85.27% |
* Healthcare Sector Average
JP:2373
Care Twentyone Corporation
404.00
-3.18
-0.78%
JP:2425
Care Service Co., Ltd.
678.00
-78.28
-10.35%
JP:6062
Charm Care Corporation
1,454.00
347.02
31.35%
JP:7362
Terminalcare Support Institute, Inc.
850.00
15.12
1.81%
JP:9220
FB CARE SERVICE CO.,LTD.
1,245.00
205.52
19.77%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.